胸腹主动脉修复后内脏主动脉补片动脉瘤的开窗、杂交与腔内治疗管理
回顾1993至2016年29例胸腹主动脉瘤开放修复后内脏主动脉补片动脉瘤患者,分别接受再次开放手术14例、杂交修复10例和腔内定制开窗支架5例。复合主要不良事件评分三组分别为79%、60%和0%,差异有统计学意义(P=0.009)。作者认为当前实践倾向于优先选择腔内修复,但需更大样本或随机试验验证其优越性。
要点
- 内脏主动脉补片动脉瘤再次开放手术、杂交修复和腔内开窗支架修复的复合主要不良事件评分分别为79%、60%和0%(P=0.009)。
- 杂交修复组和腔内修复组各出现1例暂时性延迟性脊髓缺血(1级),共2例(6.9%)。
- 术中失血量≥1000 mL、输注浓缩红细胞≥3单位、ICU停留>1天和住院时间≥7天的比例在三组间差异均有统计学意义。
核心结论
- 该回顾性研究证实,胸腹主动脉瘤开放修复后发生的内脏主动脉补片动脉瘤可采用开放、杂交和腔内技术修复。
- 当前实践倾向于尽可能选择腔内修复,但需更大样本或随机试验验证其优于其他技术。
研究设计与样本
- 回顾性研究,纳入1993年至2016年间29例胸腹主动脉瘤开放修复后发生内脏主动脉补片动脉瘤的患者。
- 初次胸腹主动脉瘤开放修复至补片动脉瘤治疗的中位时间间隔为6.2年(四分位距4-8年)。
- 再次开放修复组14例(48.3%),杂交修复组10例(34.5%),腔内定制开窗支架修复组5例(17.2%)。
- 主要终点为复合主要不良事件评分:任何30天死亡加上任何≥2级术后并发症加上任何再次手术干预,按血管外科学会/美国血管外科协会报告标准分类。
- 患者在术后3、6、12个月及此后每年于门诊接受计算机断层扫描评估。
主要发现
- 复合主要不良事件评分三组间差异有统计学意义:开放组79%,杂交组60%,腔内组0%(P=0.009)。
- 暂时性延迟性脊髓缺血(1级)共2例(6.9%),分别见于腔内组和杂交组。
- 失血量≥1000 mL:开放组79%,杂交组40%,腔内组0%(P=0.007)。
- 输注浓缩红细胞≥3单位:开放组100%,杂交组90%,腔内组40%(P=0.003)。
- ICU停留>1天:开放组71%,杂交组70%,腔内组0%(P=0.014);住院时间≥7天:开放组79%,杂交组80%,腔内组20%(P=0.034)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出,需更大样本或随机试验验证腔内修复优于其他技术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to investigate the outcomes of patients with visceral aortic patch (VAP) aneurysms after open repair of thoracoabdominal aortic aneurysm (TAAA) treated with three different approaches: open, hybrid, and endovascular repair. METHODS: Between 1993 and 2016, there were 29 cases treated for VAP aneurysm after initial TAAA open repair (median time interval, 6.2 years; interquartile range, 4-8 years). Three different treatment modalities were employed: redo open repair (O group) in 14 cases (48.3%), hybrid repair (H group) in 10 cases (34.5%), and endovascular custom-made fenestrated endograft repair (E group) in 5 cases (17.2%). Early (30-day) and midterm results were recorded. The primary end point was a composite major adverse event score: any 30-day death plus any grade ≥2 postoperative complications plus any surgical revision classified according to the Society for Vascular Surgery/American Association for Vascular Surgery reporting standards. Patients were evaluated with computed tomography scans in the outpatient clinic at 3, 6, and 12 months and annually thereafter. RESULTS: The composite major adverse event score significantly differed among groups (O group, 79%; H group, 60%; E group, 0%; P = .009). Two cases (6.9%) of temporary delayed spinal cord ischemia (grade 1) were observed in both the E and H groups. The treatment modality employed was differently associated with blood loss ≥1000 mL (O group, 79%; H group, 40%; E group, 0%; P = .007), number of packed red blood cells transfused ≥3 units (O group, 100%; H group, 90%; E group, 40%; P = .003), intensive care unit stay >1 day (O group, 71%; H group, 70%; E group, 0%; P = .014), and length of hospital stay ≥7 days (O group, 79%; H group, 80%, E group, 20%; P = .034). At short term (6 months), we observed one endovascular reintervention in the E group and one fatal visceral graft thrombosis in the H group. At a median follow-up of 30 months (interquartile range, 15-75 months), we observed another aneurysm-related death in the H group due to graft infection and four unrelated deaths (one case in the H group and two cases in the O group). CONCLUSIONS: This retrospective study confirms that repair of VAP aneurysms that develop after open repair of TAAAs can be performed with open, hybrid, and endovascular techniques. Current practice favors endovascular repair if possible, but a conclusion that it is superior to any other technique requires validation in a larger sample or a randomized trial.
引用
- Bertoglio L, Mascia D, Cambiaghi T, et al. Management of visceral aortic patch aneurysms after thoracoabdominal repair with open, hybrid, or endovascular approach. J Vasc Surg. 2018. PMID: 29685248. doi:10.1016/j.jvs.2017.09.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。